Literature DB >> 28444398

Plasma Transfusion Demystified: A Review of the Key Factors Influencing the Response to Plasma Transfusion.

Allen W Bryan1, Elizabeth M Staley1, Timothy Kennell2, Alexander Z Feldman1, Lance A Williams1, Huy P Pham1.   

Abstract

Many studies have suggested that inappropriate plasma usage is common. An important factor contributing to futile plasma administration in most patients is the nonlinear relationship between coagulation-factor levels and the volume of plasma transfused. In this review, a validated mathematical model and data from the literature will be used to illuminate 3 key properties of plasma transfusion. Those properties are as follows: the effect of plasma transfusion on international normalized ratio (INR) is transient; for the same volume of transfused plasma, a greater reduction in INR is observed at higher initial INRs; and the effect of plasma transfusion on INR correction (ie, the difference between initial and final INRs) diminishes as more plasma is transfused. Frequent misunderstanding of these properties may contribute to inappropriate plasma usage. Therefore, this review will assist physicians in navigating these common pitfalls. Stronger understanding of these principles may result in a reduction of inappropriate plasma transfusions, thus potentially enhancing patient safety and reducing healthcare costs. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  plasma usage, coagulopathy management, pre-operativezzm321990 management; blood transfusion; guidelines; mathematical model

Mesh:

Year:  2017        PMID: 28444398      PMCID: PMC6251590          DOI: 10.1093/labmed/lmx027

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  23 in total

1.  Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization.

Authors:  Jacob C Townsend; Richard Heard; Eric R Powers; Adrian Reuben
Journal:  Am J Cardiol       Date:  2012-06-22       Impact factor: 2.778

2.  Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction.

Authors:  Ravindra Sarode; Majed A Refaai; Karen Matevosyan; James D Burner; Scott Hampton; Cynthia Rutherford
Journal:  Transfusion       Date:  2009-10-05       Impact factor: 3.157

3.  Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation.

Authors:  C K Okerberg; L A Williams; M L Kilgore; C H Kim; M B Marques; J Schwartz; H P Pham
Journal:  Vox Sang       Date:  2016-06-01       Impact factor: 2.144

4.  Mathematical model and calculation to predict the effect of prophylactic plasma transfusion on change in international normalized ratio in critically ill patients with coagulopathy.

Authors:  Huy P Pham; Marcella C Müller; Lance A Williams; Nicole P Juffermans
Journal:  Transfusion       Date:  2015-12-31       Impact factor: 3.157

5.  Effect of plasma transfusions on the prothrombin time and clotting factors in liver disease.

Authors:  I Spector; M Corn; H E Ticktin
Journal:  N Engl J Med       Date:  1966-11-10       Impact factor: 91.245

6.  Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.

Authors:  Alexis R Harvey; Sridhar V Basavaraju; Koo-Whang Chung; Matthew J Kuehnert
Journal:  Transfusion       Date:  2014-11-05       Impact factor: 3.157

Review 7.  Reduction in plasma transfusion after enforcement of transfusion guidelines.

Authors:  Maria Tavares; Pamela DiQuattro; Norma Nolette; Gina Conti; Joseph Sweeney
Journal:  Transfusion       Date:  2010-10-04       Impact factor: 3.157

8.  Utilization of frozen plasma in Ontario: a provincewide audit reveals a high rate of inappropriate transfusions.

Authors:  Alan Tinmouth; Troy Thompson; Donald M Arnold; Jeannie L Callum; Kate Gagliardi; Deborah Lauzon; Wendy Owens; Peter Pinkerton
Journal:  Transfusion       Date:  2013-05-14       Impact factor: 3.157

9.  Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.

Authors:  Ravi Sarode; Truman J Milling; Majed A Refaai; Antoinette Mangione; Astrid Schneider; Billie L Durn; Joshua N Goldstein
Journal:  Circulation       Date:  2013-08-09       Impact factor: 29.690

10.  Cost-Effectiveness Analysis of Plasma Versus Recombinant Factor VIIa for Placing Intracranial Pressure Monitors in Pretransplant Patients With Acute Liver Failure.

Authors:  Huy P Pham; Anthony N Sireci; Chong H Kim; Joseph Schwartz
Journal:  Clin Appl Thromb Hemost       Date:  2014-03-18       Impact factor: 2.389

View more
  3 in total

1.  ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis.

Authors:  Chong H Kim; Sierra C Simmons; Lance A Williams; Elizabeth M Staley; X Long Zheng; Huy P Pham
Journal:  Transfusion       Date:  2017-06-23       Impact factor: 3.157

Review 2.  Sepsis-Pathophysiology and Therapeutic Concepts.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Front Med (Lausanne)       Date:  2021-05-14

3.  Plasma Transfusion Practice in Adult Surgical Patients: Systematic Review of the Literature.

Authors:  Elisabeth Hannah Adam; Dania Fischer
Journal:  Transfus Med Hemother       Date:  2020-09-18       Impact factor: 3.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.